Efficacy and safety of maintenance therapy with pamiparib versus placebo for advanced gastric cancer responding to first‐line platinum‐based chemotherapy: Phase 2 study results.

MLA

Ciardiello, Fortunato, et al. “Efficacy and Safety of Maintenance Therapy with Pamiparib versus Placebo for Advanced Gastric Cancer Responding to First‐line Platinum‐based Chemotherapy: Phase 2 Study Results.” Cancer Medicine, vol. 12, no. 12, June 2023, pp. 13145–54. EBSCOhost, https://doi.org/10.1002/cam4.5997.

APA

Ciardiello, F., Bang, Y., Cervantes, A., Dvorkin, M., Lopez, C. D., Metges, J., Sánchez, R. A., Calvo, M., Strickland, A. H., Kannourakis, G., Muro, K., Kawakami, H., Wei, J., Borg, C., Zhu, Z., Gupta, N., Pelham, R. J., & Shen, L. (2023). Efficacy and safety of maintenance therapy with pamiparib versus placebo for advanced gastric cancer responding to first‐line platinum‐based chemotherapy: Phase 2 study results. Cancer Medicine, 12(12), 13145–13154. https://doi.org/10.1002/cam4.5997

Chicago

Ciardiello, Fortunato, Yung‐Jue Bang, Andrés Cervantes, Mikhail Dvorkin, Charles D. Lopez, Jean‐Philippe Metges, Ruiz, Antonio Sánchez, et al. 2023. “Efficacy and Safety of Maintenance Therapy with Pamiparib versus Placebo for Advanced Gastric Cancer Responding to First‐line Platinum‐based Chemotherapy: Phase 2 Study Results.” Cancer Medicine 12 (12): 13145–54. doi:10.1002/cam4.5997.